Cancer Registry Software Market Report
RA01317
Cancer Registry Software Market, by Type (Standalone Software, Integrated Software), Functionality (Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies), Deployment Model (On-premise, Cloud-based), Type Of Database (Commercial Databases, Public Databases), End User (Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global cancer registry software market is estimated to surpass $122.7 million by 2027, exhibiting a CAGR of 10.3% from 2020 to 2027.
The report aims to cater scrupulous analysis of the global cancer registry software market by methodically reviewing different facets of the market such as key segments, market dynamics, regional market circumstances, investment opportunities, and top players operating in the market.
In addition, the report offers insights on the current lookout and upcoming trends and developments that are likely to contribute to the growth of the market. Moreover, major factors such as market drivers and opportunities that are expected to shape the panorama of the global market are deliberated in the report. Also, limitations and threats that hold the power to hinder the industry growth are outlined in the report. The report also presents the Porter’s five forces analysis of the market which explains competitive landscape, negotiating power of buyers and suppliers, threats of new players, and arrival of substitutes in the market.
The report further presents future outlook and growth of the global market by scrutinizing the key forces that are likely to impact the market growth. The report also reveals segmental analysis by acutely assessing every segment of the global cancer registry software market. Regional market analysis of these segments is also presented in the report. The report divides the global cancer registry software market into four main regions including Europe, North America, Asia-Pacific, and LAMEA. Further, these regions are sub-divided to explain in detail the landscape of the cancer registry software market across major countries in these regions. Furthermore, the report divulges some of the recent advances, trends, and upcoming opportunities in every region.
The report offers a complete overview of 10 foremost players operating in the global cancer registry software market along with their company overview, major company executives, company’s financial status and revenue, top business activities, and groundbreaking developments in the global cancer registry software market. Besides these insights, the major events as well as strategies of major players functioning in the global cancer registry software market is also provided in the report.
RESEARCH METHODOLOGY
The report is articulated by Research Dive’s professional market analysts, and claims to be a reliable source of data and statistics for the global cancer registry software market. The market forecasts specified in the report have been derived using proven research methodologies and analytical tools & models. Use of such advanced tools helps market analysts in analyzing, filtering, and deriving precise data and predictions.
The report is formulated after a thorough conversation and interviews with top industry players, stakeholders, and market participants. All the research and analysis is based on data obtained from reliable and renowned sources of statistics, and regional intelligence. The research report is built by gathering various data points and information regarding the cancer registry software market. Primary research forms the foundation of the overall research process; however, it is reasonably supported by comprehensive secondary research. Around 5,900 product type literatures, company annual reports, market publications, and other such significant documents of key market players have been reviewed for in-depth understanding of market saturation. Additionally, trade associations’ publications, reliable industry bulletins, medical journals, and government websites have been studied for getting hold of important industry related insights.
KEY MARKET BENEFITS
- The report reveals market size and forecast for the period from 2019 to 2027
- This report sheds light on trends, inventions, and novel developments along with a detailed quantitative breakdown of the cancer registry software market during the period of forecast
- The report offers prevalent as well as upcoming investment opportunities of the global cancer registry software market
- The market size and estimations are based on a comprehensive analysis of market drivers and restraints and key improvements in the cancer registry software market
- The report also offers insights on foremost market players, Porter’s Five Analysis, and top winning business strategies
- The initiatives undertaken by the top market players are presented in the report to comprehend the competitive scenario of the market
KEY MARKET SEGMENTS
The report segments the global market into type ,functionality ,deployment model ,type of database ,end user and region.
- Type: Standalone Software, Integrated Software
- Functionality: Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies
- Deployment Model: On-premise, Cloud-based
- Type Of Database: Commercial Databases, Public Databases
- End User: Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers
Regionally, the report assesses the global market across North America, Europe, Asia Pacific, and LAMEA.
- The North American countries evaluated in the report are the U.S., Canada, and Mexico
- The European countries evaluated in the report are Germany, UK, France, Spain, Italy, and Rest of Europe
- The Asian countries evaluated in the report are Japan, China, India, Australia, and Rest of Asia-Pacific
- The countries in LAMEA evaluated in the report are Brazil, Saudi Arabia, South Africa, South Korea, and Rest of LAMEA
KEY PLAYERS
The key players outlined in the report are Electronic Registry Systems, Inc., Elekta, McKesson Corporation, Elekta.
The report summaries the business overview including financial performance, latest strategic moves & developments, product portfolio, and SWOT analysis of the top players functioning in the cancer registry software market.
1. Elekta
2. Electronic Registry Systems, Inc.
3. Onco, Inc.
4. C/NET Solutions
5. Rocky Mountain Cancer Data Systems
6. McKesson Corporation
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Cancer Registry Software Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Cancer Registry Software Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Cancer Registry Software Market, By Infections
5.1. Overview
5.2 Standalone Software
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Integrated Software
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Research Dive Exclusive Insights
5.4.1 Market attractiveness
5.4.2 Competition heatmap
-
6. Cancer Registry Software Market, By Service Provider
6.1. Overview
6.2 Cancer Reporting to Meet State & Federal Regulations
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Patient Care Management
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Product Outcome Evaluation
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Medical Research and Clinical Studies
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Research Dive Exclusive Insights
6.6.1 Market attractiveness
6.6.2 Competition heatmap
-
7. Cancer Registry Software Market, By Market
7.1. Overview
7.2 On-premise
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Cloud-based
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Research Dive Exclusive Insights
7.4.1 Market attractiveness
7.4.2 Competition heatmap
-
8. Cancer Registry Software Market, By Organ Type
8.1. Overview
8.2 Commercial Databases
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Public Databases
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
-
9. Cancer Registry Software Market,
9.1. Overview
9.2 Government Organizations & Third-party Administrators (TPAS)
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Hospitals & Medical Practices
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Pharmaceutical, Biotechnology, & Medical Device Companies
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Private Payers
9.5.1 Definition, key trends, growth factors, and opportunities
9.5.2 Market size analysis, by region, 2020-2027
9.5.3 Market share analysis, by country, 2020-2027
9.6 Research Centers
9.6.1 Definition, key trends, growth factors, and opportunities
9.6.2 Market size analysis, by region, 2020-2027
9.6.3 Market share analysis, by country, 2020-2027
9.7 Research Dive Exclusive Insights
9.7.1 Market attractiveness
9.7.2 Competition heatmap
10. Cancer Registry Software Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Infections, 2020-2027
10.1.1.2 Market size analysis, By Service Provider, 2020-2027
10.1.1.3 Market size analysis, By Market, 2020-2027
10.1.1.4 Market size analysis, By Organ Type, 2020-2027
10.1.1.5 Market size analysis, , 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Infections, 2020-2027
10.1.2.2 Market size analysis, By Service Provider, 2020-2027
10.1.2.3 Market size analysis, By Market, 2020-2027
10.1.2.4 Market size analysis, By Organ Type, 2020-2027
10.1.2.5 Market size analysis, , 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Infections, 2020-2027
10.1.3.2 Market size analysis, By Service Provider, 2020-2027
10.1.3.3 Market size analysis, By Market, 2020-2027
10.1.3.4 Market size analysis, By Organ Type, 2020-2027
10.1.3.5 Market size analysis, , 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Infections, 2020-2027
10.2.1.2 Market size analysis, By Service Provider, 2020-2027
10.2.1.3 Market size analysis, By Market, 2020-2027
10.2.1.4 Market size analysis, By Organ Type, 2020-2027
10.2.1.5 Market size analysis, , 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Infections, 2020-2027
10.2.2.2 Market size analysis, By Service Provider, 2020-2027
10.2.2.3 Market size analysis, By Market, 2020-2027
10.2.2.4 Market size analysis, By Organ Type, 2020-2027
10.2.2.5 Market size analysis, , 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Infections, 2020-2027
10.2.3.2 Market size analysis, By Service Provider, 2020-2027
10.2.3.3 Market size analysis, By Market, 2020-2027
10.2.3.4 Market size analysis, By Organ Type, 2020-2027
10.2.3.5 Market size analysis, , 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Infections, 2020-2027
10.2.4.2 Market size analysis, By Service Provider, 2020-2027
10.2.4.3 Market size analysis, By Market, 2020-2027
10.2.4.4 Market size analysis, By Organ Type, 2020-2027
10.2.4.5 Market size analysis, , 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Infections, 2020-2027
10.2.5.2 Market size analysis, By Service Provider, 2020-2027
10.2.5.3 Market size analysis, By Market, 2020-2027
10.2.5.4 Market size analysis, By Organ Type, 2020-2027
10.2.5.5 Market size analysis, , 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Infections, 2020-2027
10.2.6.2 Market size analysis, By Service Provider, 2020-2027
10.2.6.3 Market size analysis, By Market, 2020-2027
10.2.6.4 Market size analysis, By Organ Type, 2020-2027
10.2.6.5 Market size analysis, , 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Infections, 2020-2027
10.3.1.2 Market size analysis, By Service Provider, 2020-2027
10.3.1.3 Market size analysis, By Market, 2020-2027
10.3.1.4 Market size analysis, By Organ Type, 2020-2027
10.3.1.5 Market size analysis, , 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Infections, 2020-2027
10.3.2.2 Market size analysis, By Service Provider, 2020-2027
10.3.2.3 Market size analysis, By Market, 2020-2027
10.3.2.4 Market size analysis, By Organ Type, 2020-2027
10.3.2.5 Market size analysis, , 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Infections, 2020-2027
10.3.3.2 Market size analysis, By Service Provider, 2020-2027
10.3.3.3 Market size analysis, By Market, 2020-2027
10.3.3.4 Market size analysis, By Organ Type, 2020-2027
10.3.3.5 Market size analysis, , 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Infections, 2020-2027
10.3.4.2 Market size analysis, By Service Provider, 2020-2027
10.3.4.3 Market size analysis, By Market, 2020-2027
10.3.4.4 Market size analysis, By Organ Type, 2020-2027
10.3.4.5 Market size analysis, , 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Infections, 2020-2027
10.3.5.2 Market size analysis, By Service Provider, 2020-2027
10.3.5.3 Market size analysis, By Market, 2020-2027
10.3.5.4 Market size analysis, By Organ Type, 2020-2027
10.3.5.5 Market size analysis, , 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Infections, 2020-2027
10.3.6.2 Market size analysis, By Service Provider, 2020-2027
10.3.6.3 Market size analysis, By Market, 2020-2027
10.3.6.4 Market size analysis, By Organ Type, 2020-2027
10.3.6.5 Market size analysis, , 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Infections, 2020-2027
10.4.1.2 Market size analysis, By Service Provider, 2020-2027
10.4.1.3 Market size analysis, By Market, 2020-2027
10.4.1.4 Market size analysis, By Organ Type, 2020-2027
10.4.1.5 Market size analysis, , 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Infections, 2020-2027
10.4.2.2 Market size analysis, By Service Provider, 2020-2027
10.4.2.3 Market size analysis, By Market, 2020-2027
10.4.2.4 Market size analysis, By Organ Type, 2020-2027
10.4.2.5 Market size analysis, , 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Infections, 2020-2027
10.4.3.2 Market size analysis, By Service Provider, 2020-2027
10.4.3.3 Market size analysis, By Market, 2020-2027
10.4.3.4 Market size analysis, By Organ Type, 2020-2027
10.4.3.5 Market size analysis, , 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Infections, 2020-2027
10.4.4.2 Market size analysis, By Service Provider, 2020-2027
10.4.4.3 Market size analysis, By Market, 2020-2027
10.4.4.4 Market size analysis, By Organ Type, 2020-2027
10.4.4.5 Market size analysis, , 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Infections, 2020-2027
10.4.5.2 Market size analysis, By Service Provider, 2020-2027
10.4.5.3 Market size analysis, By Market, 2020-2027
10.4.5.4 Market size analysis, By Organ Type, 2020-2027
10.4.5.5 Market size analysis, , 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 Elekta
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 Electronic Registry Systems, Inc.
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 Onco, Inc.
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 C/NET Solutions
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 Rocky Mountain Cancer Data Systems
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 McKesson Corporation
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
